Ledger.Open graph →
SEC Form D · filed July 10, 2025

Armis Biopharma, Inc

Offering
$3.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FORT COLLINS, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Alan Ruud · Fort Collins, CADirectorSteve Coder · Fort Collins, COExec · DirectorMichael Litwack · Fort Collins, CODirectorAlan Smith, Ph.D · Fort Collins, CODirectorTheodore Ziemann · Fort Collins, CODirectorMichael Voss · Fort Collins, COExec · DirectorWilliam Nelson, Md, Ph.D · Fort Collins, CODirectorChristopher Rudd · Fort Collins, CODirectorChristopher Rudd · Fort Collins, CODirectorTheodore Ziemann · Fort Collins, CODirectorAlan Ruud · Fort Collins, CADirectorSteve Coder · Fort Collins, COExec · DirectorMichael Voss · Fort Collins, COExec · DirectorWilliam Nelson, Md, Ph.D · Fort Collins, CODirectorMichael Litwack · Fort Collins, CODirectorAlan Smith, Ph.D · Fort Collins, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗